We develop advanced deep-tech and AI imaging software to comprehensively assess bone microarchitecture and predict fracture risk in primary and secondary osteoporosis.

By leveraging Trabecular Bone Score, our multimodal imaging software empower clinicians to improve detection of bone fragilities, initiate treatment plans, and monitor response over time.

Our medical solutions are

Clinician friendly

Designed with clinicians in mind, our software tools seamlessly integrate into clinical routine.

Patient-centric

Non-invasive and pain-free technology requiring no additional radiation and time for patients.

Time efficient

Fast processing time
freeing-up clinicians' time
to focus on
patient care.

The gold standard for osteoporosis fracture risk assessment

TBS Osteo is an AI-ready technology and state-of-the-art software powered by TBS iNsight to evaluate bone microarchitecture in patients during a DXA bone densitometry scan. It provides the missing link needed to identify more patients at risk of fracture.
Since 2022, TBS Osteo benefits from 4 dedicated CPT® codes for Medicare beneficiaries. Reimbursement under the PFS and OPPS have steadily increased in the USA.

TBS Osteo: a trusted bone health solution in the world’s top hospitals

TBS Osteo has been adopted by the World’s Best Hospitals in 2023 as listed in Newsweek. Not only is TBS Osteo present in more than half of the top 250 hospitals, but it is also trusted by the top 15 hospitals on this list.

This widespread adoption of TBS Osteo in the world’s foremost hospitals represents a pivotal juncture in clinical practice and bone health assessment across the globe. It marks a departure from conventional methods, where assessments primarily focused on BMD. Now, with TBS gaining prevalence in the world’s leading hospitals, there’s a tangible acknowledgment of the significance of considering not just density but also the bone microarchitecture.

TBS provides additional beneficial clinical insights into fracture risk. We routinely report TBS on virtually everyone. TBS is really the first major DXA advance in years.

Prof. Neil Binkley, Department of Medicine University of Wisconsin, Madison, USA

Assessing information related to bone microarchitecture in addition to bone density and clinical risk factors provides a more complete assessment to inform management decisions for the benefit of the patient.

Prof. E. McCloskey, Department of Oncology and Metabolism at Sheffield University, UK

3M

worldwide procedures/year

30

guidelines

60

countries

1200

publications

Building the future
We develop innovative medical imaging AI applications and provide professional services.

TBS Osteo v4

Coming soon: the next generation TBS Osteo version 4 brings a novel soft tissue thickness algorithm to broaden the patient population in scope.

Learn more

TBS Reveal

TBS Reveal offers a proactive cost-effective method for widespread bone health assessment. This software utilizes existing images from conventional X-ray and CT acquisitions.

Learn more

TBS Ortho

TBS Ortho aims to provide orthopedic surgeons with unmet bone quality insights for pre-operative planning and post-operative assessment.

Learn more

Partnerships

We provide professional services to pharmaceutical companies, clinical research organizations and medical research organizations.

Learn more

Clinical news & media

21/11/2024 - Media - Press articles

Bone Deep: Unveiling the myths and realities of Osteoporosis – David Lee

27/09/2024 - Media - Press releases

Award-winning study confirms Medimaps Group new AI software accurately assesses bone fragility from routine X-rays

19/09/2024 - Clinical news

Artificial intelligence-based, automatic and explainable bone fragility detection from X-ray: a multi-national cohort study

Next events

GRIO 2025

Paris, France

17/01 - 17/01

Georgia Society of Endocrinology Annual Meeting

Atlanta, United States

31/01 - 01/02

ISCD Annual Meeting 2025

Boston, United States

20/02 - 22/02

Our global DXA partners